PL2082226T3 - Sekwencyjna analiza próbek biologicznych - Google Patents

Sekwencyjna analiza próbek biologicznych

Info

Publication number
PL2082226T3
PL2082226T3 PL07871481T PL07871481T PL2082226T3 PL 2082226 T3 PL2082226 T3 PL 2082226T3 PL 07871481 T PL07871481 T PL 07871481T PL 07871481 T PL07871481 T PL 07871481T PL 2082226 T3 PL2082226 T3 PL 2082226T3
Authority
PL
Poland
Prior art keywords
sample
fluorescent probe
binding
detecting
probe
Prior art date
Application number
PL07871481T
Other languages
English (en)
Inventor
Zhengyu Pang
Robert John Filkins
Michael Christopher Montalto
Fiona Ginty
Michael J Gerdes
Ali Can
Maureen Ann Bresnahan
Anup Sood
Original Assignee
Gen Electric
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/560,599 external-priority patent/US7629125B2/en
Application filed by Gen Electric filed Critical Gen Electric
Publication of PL2082226T3 publication Critical patent/PL2082226T3/pl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
PL07871481T 2006-11-16 2007-11-15 Sekwencyjna analiza próbek biologicznych PL2082226T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11/560,599 US7629125B2 (en) 2006-11-16 2006-11-16 Sequential analysis of biological samples
US11/864,085 US7741045B2 (en) 2006-11-16 2007-09-28 Sequential analysis of biological samples
PCT/US2007/084800 WO2008064067A2 (en) 2006-11-16 2007-11-15 Method for the sequential analysis of different components in a single biological sample and reagents therefor
EP07871481A EP2082226B1 (en) 2006-11-16 2007-11-15 Sequential analysis of biological samples

Publications (1)

Publication Number Publication Date
PL2082226T3 true PL2082226T3 (pl) 2012-01-31

Family

ID=39313177

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07871481T PL2082226T3 (pl) 2006-11-16 2007-11-15 Sekwencyjna analiza próbek biologicznych

Country Status (11)

Country Link
US (1) US7741045B2 (pl)
EP (2) EP2082226B1 (pl)
JP (1) JP5149303B2 (pl)
AT (1) ATE520026T1 (pl)
AU (1) AU2007323794B2 (pl)
CA (1) CA2669092C (pl)
DK (1) DK2082226T3 (pl)
ES (1) ES2459725T3 (pl)
PL (1) PL2082226T3 (pl)
PT (1) PT2082226E (pl)
WO (1) WO2008064067A2 (pl)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8131476B2 (en) * 2006-08-07 2012-03-06 General Electric Company System and method for co-registering multi-channel images of a tissue micro array
US8060348B2 (en) * 2006-08-07 2011-11-15 General Electric Company Systems for analyzing tissue samples
US20080032321A1 (en) * 2006-08-07 2008-02-07 General Electric Company System and methods for analyzing images of tissue samples
US7629125B2 (en) * 2006-11-16 2009-12-08 General Electric Company Sequential analysis of biological samples
US20100279272A1 (en) * 2008-02-13 2010-11-04 Michael Craig Burrell Multiplexed analysis methods using sers-active nanoparticles
EP2110076A1 (en) * 2008-02-19 2009-10-21 Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Method and device for near-field dual-wave modality imaging
US9572497B2 (en) 2008-07-25 2017-02-21 Helmholtz Zentrum Munchen Deutsches Forschungszentrum Fur Gesundheit Und Umwelt (Gmbh) Quantitative multi-spectral opto-acoustic tomography (MSOT) of tissue biomarkers
US9271654B2 (en) 2009-06-29 2016-03-01 Helmholtz Zentrum Munchen Deutsches Forschungszentrum Fur Gesundheit Und Umwelt (Gmbh) Thermoacoustic imaging with quantitative extraction of absorption map
JP5808741B2 (ja) 2009-07-27 2015-11-10 ヘルムホルツ・ツェントルム・ミュンヒェン・ドイチェス・フォルシュンクスツェントルム・フューア・ゲズントハイト・ウント・ウムベルト(ゲーエムベーハー)Helmholtz Zentrum MuenchenDeutsches Forschungszentrum fuer Gesundheit und Umwelt (GmbH) 小動物の光音響イメージング用画像化装置及び画像化方法
US8269827B2 (en) * 2009-09-29 2012-09-18 General Electric Company System and methods for mapping fluorescent images into a bright field color space
US9677125B2 (en) * 2009-10-21 2017-06-13 General Electric Company Detection of plurality of targets in biological samples
EP2633080B1 (en) 2010-10-29 2018-12-05 President and Fellows of Harvard College Method of detecting targets using fluorescently labelled nucleic acid nanotube probes
US20120271553A1 (en) * 2011-04-22 2012-10-25 Ge Global Research Analyzing the expression of biomarkers in cells with clusters
US8639013B2 (en) 2011-08-17 2014-01-28 General Electric Company System and methods for generating a brightfield image using fluorescent images
US9176032B2 (en) 2011-12-23 2015-11-03 General Electric Company Methods of analyzing an H and E stained biological sample
US8568991B2 (en) 2011-12-23 2013-10-29 General Electric Company Photoactivated chemical bleaching of dyes
WO2013137715A1 (en) * 2012-03-16 2013-09-19 Umc Utrecht Holding B.V. Biomarkers for adverse cardiac remodeling
ES2678211T3 (es) 2012-03-27 2018-08-09 Ventana Medical Systems, Inc. Conjugados de señalización y procedimientos de uso
CA2867359A1 (en) 2012-03-30 2013-10-03 Clarient Diagnostic Services, Inc. Methods for generating an image of a biological sample
US20140024024A1 (en) * 2012-07-17 2014-01-23 General Electric Company Methods of detecting dna, rna and protein in biological samples
EP2742854B1 (en) 2012-12-11 2021-03-10 iThera Medical GmbH Handheld device and method for tomographic optoacoustic imaging of an object
EP2754388B1 (en) 2013-01-15 2020-09-09 Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH System and method for quality-enhanced high-rate optoacoustic imaging of an object
EP2965087B1 (en) 2013-03-06 2018-10-17 General Electric Company Methods of analyzing an h&e stained biological sample
JP2016528175A (ja) * 2013-06-04 2016-09-15 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft Fretに有用な新規化合物およびそれに関連する方法
CA2919833A1 (en) 2013-07-30 2015-02-05 President And Fellows Of Harvard College Quantitative dna-based imaging and super-resolution imaging
US9778263B2 (en) 2013-11-13 2017-10-03 General Electric Company Quantitative in situ characterization of biological samples
KR102235201B1 (ko) * 2014-03-05 2021-04-05 유씨엘 비즈니스 리미티드 T 세포 수용체 베타 불변 영역에 대한 항원 결합 도메인을 갖는 키메라 항원 수용체(car)
US20230027993A1 (en) 2014-03-05 2023-01-26 Autolus Limited Methods
EP4245859A3 (en) * 2014-03-11 2023-11-08 President and Fellows of Harvard College High-throughput and highly multiplexed imaging with programmable nucleic acid probes
EP3175023A4 (en) 2014-07-30 2018-03-07 President and Fellows of Harvard College Systems and methods for determining nucleic acids
US9933431B2 (en) 2014-08-22 2018-04-03 Arizona Board Of Regents On Behalf Of Arizona State University System and method for iterative detection of biological molecules
EP3037820A1 (en) 2014-12-27 2016-06-29 Miltenyi Biotec GmbH Cell detection methods and reagents having a releasable labelling moiety
US10839509B2 (en) 2015-07-10 2020-11-17 3Scan Inc. Spatial multiplexing of histological stains
CN108350486B (zh) 2015-07-17 2021-09-03 纳米线科技公司 在横切面组织的用户定义区域中的基因表达的同时定量
US20170241911A1 (en) 2016-02-22 2017-08-24 Miltenyi Biotec Gmbh Automated analysis tool for biological specimens
US10871490B2 (en) 2016-02-29 2020-12-22 Multenyi Biotec, gmbH Assay for detection of chimeric antigen receptor T cells
US20190292259A1 (en) 2016-05-24 2019-09-26 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods and pharmaceutical compositions for the treatment of non small cell lung cancer (nsclc) that coexists with chronic obstructive pulmonary disease (copd)
CN109475864B (zh) 2016-06-29 2022-03-04 美天施生物科技有限两合公司 用于生物试样的多级一次性筒
CN106290878A (zh) * 2016-09-10 2017-01-04 天津大学 基于量子点的胰腺癌肿瘤标志物ca242免疫层析试纸条的制备方法
JP2020504600A (ja) 2016-12-09 2020-02-13 アルティヴュー, インク. 標識化核酸イメージング剤を使用した多重イメージングのための改善された方法
WO2018122249A1 (en) 2016-12-28 2018-07-05 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting the survival time of patients suffering from a microsatellite stable colorectal cancer
WO2018122245A1 (en) 2016-12-28 2018-07-05 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods of predicting the survival time of patients suffering from cms3 colorectal cancer
CA3061429A1 (en) 2017-05-05 2018-11-08 Inserm (Institut National De La Sante Et De La Recherche Medicale) Microtubule-targeting drugs as immune checkpoint inhibitors and methods of screening novel immune checkpoint inhibitors for the treatment of cancers and infectious diseases
WO2018218150A1 (en) 2017-05-26 2018-11-29 President And Fellows Of Harvard College Systems and methods for high-throughput image-based screening
EP3489684B1 (en) 2017-11-27 2024-06-26 Miltenyi Biotec B.V. & Co. KG Method for photobleaching stained cells
AU2019216973A1 (en) 2018-02-12 2020-08-27 Bruker Spatial Biology, Inc. Biomolecular probes and methods of detecting gene and protein expression
JP2020071152A (ja) * 2018-10-31 2020-05-07 ソニー株式会社 免疫染色方法、免疫染色システム、および免疫染色キット
BR112021013157A8 (pt) 2019-01-03 2022-12-06 Inst Nat Sante Rech Med Usos de um inibidor de nrp-1, uso de uma combinação, uso de um anticorpo multiespecífico, método ex vivo para predizer, uso de um inibidor, anticorpo multiespecífico, população de células modificadas, método ex vivo de produção e uso de uma população de células t
CN109770853B (zh) * 2019-01-30 2022-01-14 上海师范大学 一种斑马鱼伤口检测方法
US11633741B2 (en) 2019-03-19 2023-04-25 Miltenyi Biotec B.V. & Co. KG Slide chamber
JP2022527972A (ja) 2019-04-02 2022-06-07 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 前悪性病変を有する患者において癌を予測及び予防する方法
US20220160692A1 (en) 2019-04-09 2022-05-26 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of sk2 inhibitors in combination with immune checkpoint blockade therapy for the treatment of cancer
JP7354285B2 (ja) 2019-04-23 2023-10-02 ミルテニー バイオテック ベー.フェー. ウント コー. カー・ゲー 蛍光輝度を増加させるためのリンカー及び酵素により遊離可能な蛍光部分を有する接合体での可逆的な細胞検出
CN114072676B (zh) 2019-06-03 2024-07-12 法国国家卫生及研究医学协会 调节治疗方案的方法
CN114729890A (zh) * 2019-10-17 2022-07-08 C2感官有限公司 用于感测和/或认证的发光成像
US11796539B2 (en) 2019-10-17 2023-10-24 C2Sense, Inc. Systems and methods for determining a characteristic of an emissive species
CA3157889A1 (en) 2019-10-17 2021-04-22 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods for diagnosing nasal intestinal type adenocarcinomas
US20230113705A1 (en) 2020-02-28 2023-04-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for diagnosing, prognosing and managing treatment of breast cancer
EP3916393B1 (en) * 2020-05-27 2023-01-25 Miltenyi Biotec B.V. & Co. KG Method for detection of cells by repetitive staining and destaining
EP3916388A1 (en) 2020-05-27 2021-12-01 Miltenyi Biotec B.V. & Co. KG Reagents for detection of chimeric antigen receptor cells
WO2022002874A1 (en) 2020-06-30 2022-01-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting the risk of recurrence and/or death of patients suffering from a solid cancer after preoperative adjuvant therapy and radical surgery
EP4172621A1 (en) 2020-06-30 2023-05-03 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting the risk of recurrence and/or death of patients suffering from a solid cancer after preoperative adjuvant therapies
WO2022200303A1 (en) 2021-03-23 2022-09-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the diagnosis and treatment of t cell-lymphomas
US20240241128A1 (en) 2021-04-09 2024-07-18 Neogenomics Laboratories, Inc. Perivascular accumulation of immune cells in the diagnosis and treatment of cancer
CN113684256B (zh) * 2021-08-30 2024-05-14 中国药科大学 基于绿色溶剂及可编程寡核苷酸探针的多重定位检测多种靶标的方法
WO2023143179A1 (zh) * 2022-01-28 2023-08-03 南京大学 一种对抗原样本的处理方法和应用
WO2023144303A1 (en) 2022-01-31 2023-08-03 INSERM (Institut National de la Santé et de la Recherche Médicale) Cd38 as a biomarker and biotarget in t-cell lymphomas
WO2023175366A1 (en) 2022-03-17 2023-09-21 Veracyte Methods for predicting response to an immunotherapeutic treatment in a patient with a cancer
WO2023198648A1 (en) 2022-04-11 2023-10-19 Institut National de la Santé et de la Recherche Médicale Methods for the diagnosis and treatment of t-cell malignancies
WO2023198874A1 (en) 2022-04-15 2023-10-19 Institut National de la Santé et de la Recherche Médicale Methods for the diagnosis and treatment of t cell-lymphomas
WO2024003310A1 (en) 2022-06-30 2024-01-04 Institut National de la Santé et de la Recherche Médicale Methods for the diagnosis and treatment of acute lymphoblastic leukemia
WO2024018046A1 (en) 2022-07-22 2024-01-25 Institut National de la Santé et de la Recherche Médicale Garp as a biomarker and biotarget in t-cell malignancies
WO2024023283A1 (en) 2022-07-29 2024-02-01 Institut National de la Santé et de la Recherche Médicale Lrrc33 as a biomarker and biotarget in cutaneous t-cell lymphomas
WO2024079192A1 (en) 2022-10-12 2024-04-18 Institut National de la Santé et de la Recherche Médicale Cd81 as a biomarker and biotarget in t-cell malignancies

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3130513B2 (ja) * 1989-04-19 2001-01-31 イビデン株式会社 生体活性物質測定用装置
US5807522A (en) * 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
DE4421891C2 (de) 1994-06-23 1996-05-15 Helmut Prof Dr Med Feucht Verfahren zum Nachweis von komplementaktivierenden IgG-Antikörpern gegen HLA-DR-Antigene
US5830645A (en) * 1994-12-09 1998-11-03 The Regents Of The University Of California Comparative fluorescence hybridization to nucleic acid arrays
DE19709348C2 (de) * 1996-05-29 1999-07-01 Schubert Walter Dr Md Automatisches Multi-Epitop-Ligand-Kartierungsverfahren
DE19717904A1 (de) * 1997-04-23 1998-10-29 Diagnostikforschung Inst Säurelabile und enzymatisch spaltbare Farbstoffkonstrukte zur Diagnostik mit Nahinfrarotlicht und zur Therapie
US6083486A (en) * 1998-05-14 2000-07-04 The General Hospital Corporation Intramolecularly-quenched near infrared fluorescent probes
US6635435B1 (en) 1998-07-10 2003-10-21 Chromagen, Inc. Fluorogenic substrates and their use
US6573043B1 (en) 1998-10-07 2003-06-03 Genentech, Inc. Tissue analysis and kits therefor
WO2000058507A1 (en) 1999-03-30 2000-10-05 Solexa Ltd. Polynucleotide sequencing
EP1218543A2 (en) * 1999-09-29 2002-07-03 Solexa Ltd. Polynucleotide sequencing
GB0002389D0 (en) * 2000-02-02 2000-03-22 Solexa Ltd Molecular arrays
DE10014685B4 (de) * 2000-03-24 2004-07-01 Schubert, Walter, Dr. Verfahren zur Identifizierung von zellspezifischen Zielstrukturen
US20020106648A1 (en) * 2000-05-05 2002-08-08 Lizardi Paul M. Highly multiplexed reporter carrier systems
US20030044353A1 (en) * 2001-01-05 2003-03-06 Ralph Weissleder Activatable imaging probes
US20050230255A1 (en) 2001-03-30 2005-10-20 Sumner Lloyd W Silver destaining method
US7219016B2 (en) * 2001-04-20 2007-05-15 Yale University Systems and methods for automated analysis of cells and tissues
US20020173053A1 (en) * 2001-04-27 2002-11-21 Bassam Damaj Multiple simultaneous antigen detection by immunohistochemistry
AU2002319613A1 (en) * 2001-07-19 2003-03-03 Signet Laboratories, Inc. Human tissue specific drug screening procedure
US8323903B2 (en) * 2001-10-12 2012-12-04 Life Technologies Corporation Antibody complexes and methods for immunolabeling
WO2003061711A2 (en) * 2002-01-16 2003-07-31 Visen Medical, Inc. Chromophore probes for optical imaging
WO2004061446A1 (en) * 2002-12-18 2004-07-22 Aclara Biosciences, Inc. Single cell analysis of membrane molecules
WO2005017485A2 (en) 2003-05-22 2005-02-24 Agdia, Inc. Multiplex enzyme-linked immunosorbent assay for detecting multiple analytes
US20050287578A1 (en) * 2004-06-28 2005-12-29 Exagen Diagnostics, Inc. Methods for RNA fluorescence in situ hybridization
JP2007033159A (ja) * 2005-07-25 2007-02-08 Assay Corp 蛍光分子で標識された測定対象物質
JPWO2007055302A1 (ja) * 2005-11-10 2009-04-30 国立大学法人富山大学 生体物質と生体物質結合性物質との結合性評価方法
US8305579B2 (en) * 2006-11-16 2012-11-06 Thomas Pirrie Treynor Sequential analysis of biological samples

Also Published As

Publication number Publication date
WO2008064067A3 (en) 2008-07-10
AU2007323794B2 (en) 2013-08-22
EP2381257A1 (en) 2011-10-26
US7741045B2 (en) 2010-06-22
JP5149303B2 (ja) 2013-02-20
US20080118934A1 (en) 2008-05-22
AU2007323794A1 (en) 2008-05-29
CA2669092C (en) 2016-07-26
WO2008064067A2 (en) 2008-05-29
PT2082226E (pt) 2011-10-31
EP2082226A2 (en) 2009-07-29
JP2010510493A (ja) 2010-04-02
ATE520026T1 (de) 2011-08-15
ES2459725T3 (es) 2014-05-12
EP2381257B1 (en) 2014-03-26
DK2082226T3 (da) 2011-11-14
EP2082226B1 (en) 2011-08-10
CA2669092A1 (en) 2008-05-29

Similar Documents

Publication Publication Date Title
PL2082226T3 (pl) Sekwencyjna analiza próbek biologicznych
PL2082230T3 (pl) Sekwencyjna analiza próbek biologicznych z wygaszaniem pośrednich sygnałów fluorescencyjnych
WO2008133728A3 (en) Sequential analysis of biological samples with intermediate bleaching of fluorescence detector
MY146468A (en) Devices and methods for detecting cells and other analytes
ATE428929T1 (de) Reagens, ausstattung und verfahren zur probenanalyse
WO2008045526A3 (en) Method and device for preparing an analyte for analysis by mass spectrometry
WO2008039946A3 (en) Integrated meter for analyzing biological samples
WO2008070865A3 (en) Materials and methods for efficient and accurate detection of analytes
WO2008105896A3 (en) Analyte determination utilizing mass tagging reagents comprising a non-encoded detectable label
WO2007030949A3 (en) Methods of diagnosing ovarian cancer and kits therefor
WO2006026020A3 (en) Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin
ATE402269T1 (de) Methoden und testsätze für annäherungstest
WO2006014351A3 (en) Exploring fluorophore microenvironments
EP1930445A4 (en) KIT AND METHOD FOR DETECTING UROTHELIAL CANCER
EP1898215A4 (en) METHOD FOR ANALYZING ENDOCRINE SUBSTANCE IN A SPECIMEN
AU2003260457A1 (en) A method and kit for the quantitative and/or qualitative detection of components in a sample
WO2005054516A3 (en) Peptide nucleic acid probes for analysis of certain staphylococcus species
WO2008072275A3 (en) Telematic system for using diagnostic reagent strips and method for acquiring calibration data
WO2011032584A3 (en) Method for sample identification in a mammal as well as a kit for performing this method
EP2407787A3 (en) Method for detection of L523S expression in biological samples
WO2004085669A3 (en) Identification and quantification of microbial species in a sample
TW200502399A (en) Recombinant virus and use thereof and method of detecting an analyte in a sample and kit thereof
WO2009120962A3 (en) Protein isoforms for diagnosis
TW200510725A (en) Diagnostic kit for liver cirrhosis comprising an antibody specific for human proto oncogenic protein
WO2007103734A3 (en) Method for quantifying an analyte in a biological sample using mass spectrometry